Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-06

Clinical Trial Update: Efficacy and Safety of Conventional and Low-dose Platinum Gemcitabine Combined With Cindilimab With Delayed Administration in First-line Treatment of Advanced Squamous Non-small Cell Lung Cancer [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update assessing efficacy and safety of platinum gemcitabine with Cindilimab in first-line advanced squamous non-small cell lung cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cindilimab (not available)
  • platinum gemcitabine

Snippet

Sponsor: People's Hospital of Quzhou | Conditions: Non Small Cell Lung Cancer | Phase 4 | Status: UNKNOWN